Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
11.35 USD | -1.32% | -3.83% | +48.93% |
13/05 | Baird Adjusts Price Target on Instil Bio to $32 From $54, Maintains Outperform Rating | MT |
10/05 | Instil Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.93% | 74.79M | |
+35.69% | 50.93B | |
+0.07% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+12.59% | 26.02B | |
-22.19% | 18.9B | |
+7.65% | 13.21B | |
+24.67% | 12.17B | |
+28.87% | 12.16B |
- Stock Market
- Equities
- TIL Stock
- News Instil Bio, Inc.
- Morgan Stanley Adjusts Instil Bio Price Target to $6 From $8, Maintains Equal Weight Rating